Hoskins M, Pearce J, Bethell A, Dankova L, Barbui C, Tol WA, van Ommeren M, de Jong J, Seedat S, Chen H, Bisson JI. Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. Br J Psychiatry. February 2015, s. 93–100. DOI10.1192/bjp.bp.114.148551. PMID25644881.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Lee DJ, Schnitzlein CW, Wolf JP, Vythilingam M, Rasmusson AM, Hoge CW. Psychotherapy Versus Pharmacotherapy for Posttraumatic Stress Disorder: Systemic Review and Meta-Analyses to Determine First-Line Treatments. Depression and Anxiety. September 2016, s. 792–806. Dostupné online. DOI10.1002/da.22511. PMID27126398. S2CID20190202.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Yonkers KA, Kornstein SG, Gueorguieva R, Merry B, Van Steenburgh K, Altemus M. Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial. JAMA Psychiatry. October 2015, s. 1037–1044. DOI10.1001/jamapsychiatry.2015.1472. PMID26351969.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Gao SY, Wu QJ, Sun C, Zhang TN, Shen ZQ, Liu CX, Gong TT, Xu X, Ji C, Huang DH, Chang Q, Zhao YH. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. BMC Med. November 2018, s. 205. DOI10.1186/s12916-018-1193-5. PMID30415641.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
De Vries C, Gadzhanova S, Sykes MJ, Ward M, Roughead E. A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants. Drug Saf. March 2021, s. 291–312. ISSN0114-5916. DOI10.1007/s40264-020-01027-x. PMID33354752. S2CID229357583.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Sheehan DV, Kamijima K. An evidence-based review of the clinical use of sertraline in mood and anxiety disorders. Int Clin Psychopharmacol. March 2009, s. 43–60. DOI10.1097/yic.0b013e3282f4b616. PMID21456103.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Zuckerbrot RA, Cheung A, Jensen PS, Stein RE, Laraque D. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management. Pediatrics. March 2018. DOI10.1542/peds.2017-4081. PMID29483200. S2CID3591358.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Nemeroff CB. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J Psychiatr Res. 2007, s. 189–206. DOI10.1016/j.jpsychires.2006.05.008. PMID16870212.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
MacQueen G, Born L, Steiner M. The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders. CNS Drug Reviews. 2001, s. 1–24. DOI10.1111/j.1527-3458.2001.tb00188.x. PMID11420570.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN, Geddes J, Gilbody S, Haddad PM, Katona C, Lewis G, Malizia A, McAllister-Williams RH, Ramchandani P, Scott J, Taylor D, Uher R. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. May 2015, s. 459–525. Dostupné online. DOI10.1177/0269881115581093. PMID25969470. S2CID8142581.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, Faraone SV. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. The American Journal of Psychiatry. November 2003, s. 1919–28. Dostupné online. DOI10.1176/appi.ajp.160.11.1919. PMID14594734. S2CID8711232.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Blier P, Habib R, Flament MF. Pharmacotherapies in the management of obsessive-compulsive disorder. Canadian Journal of Psychiatry. June 2006, s. 417–30. DOI10.1177/070674370605100703. PMID16838823. S2CID17133521.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. October 2004, s. 1969–76. DOI10.1001/jama.292.16.1969. PMID15507582.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Sousa MB, Isolan LR, Oliveira RR, Manfro GG, Cordioli AV. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder. The Journal of Clinical Psychiatry. July 2006, s. 1133–9. Dostupné v archivu pořízeném z originálu dne 12 February 2020. DOI10.4088/JCP.v67n0717. PMID16889458. S2CID25130472.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Clayton AH, Stewart RS, Fayyad R, Clary CM. Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies. Archives of Women's Mental Health. May 2006, s. 151–7. DOI10.1007/s00737-005-0111-y. PMID16292466. S2CID20606054.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R. Sertraline treatment of panic disorder: response in patients at risk for poor outcome. J Clin Psychiatry. December 2000, s. 922–7. DOI10.4088/JCP.v61n1206. PMID11206597.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Sanchez C, Reines EH, Montgomery SA. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?. International Clinical Psychopharmacology. July 2014, s. 185–96. DOI10.1097/YIC.0000000000000023. PMID24424469.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Sertraline Hydrochloride [online]. The American Society of Health-System Pharmacists [cit. 2018-01-08]. Dostupné online.Je zde použita šablona {{Cite web}} označená jako k „pouze dočasnému použití“.
kcl.ac.uk
kclpure.kcl.ac.uk
Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN, Geddes J, Gilbody S, Haddad PM, Katona C, Lewis G, Malizia A, McAllister-Williams RH, Ramchandani P, Scott J, Taylor D, Uher R. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. May 2015, s. 459–525. Dostupné online. DOI10.1177/0269881115581093. PMID25969470. S2CID8142581.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
medscape.com
Math SB, Janardhan Reddy YC. Issues In The Pharmacological Treatment of Obsessive-Compulsive Disorder: First-Line Treatment Options for OCD [online]. medscape.com, 19 July 2007 [cit. 2009-07-28]. Dostupné online.Je zde použita šablona {{Cite web}} označená jako k „pouze dočasnému použití“.
nih.gov
ncbi.nlm.nih.gov
Hoskins M, Pearce J, Bethell A, Dankova L, Barbui C, Tol WA, van Ommeren M, de Jong J, Seedat S, Chen H, Bisson JI. Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. Br J Psychiatry. February 2015, s. 93–100. DOI10.1192/bjp.bp.114.148551. PMID25644881.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Lee DJ, Schnitzlein CW, Wolf JP, Vythilingam M, Rasmusson AM, Hoge CW. Psychotherapy Versus Pharmacotherapy for Posttraumatic Stress Disorder: Systemic Review and Meta-Analyses to Determine First-Line Treatments. Depression and Anxiety. September 2016, s. 792–806. Dostupné online. DOI10.1002/da.22511. PMID27126398. S2CID20190202.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Yonkers KA, Kornstein SG, Gueorguieva R, Merry B, Van Steenburgh K, Altemus M. Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial. JAMA Psychiatry. October 2015, s. 1037–1044. DOI10.1001/jamapsychiatry.2015.1472. PMID26351969.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Gao SY, Wu QJ, Sun C, Zhang TN, Shen ZQ, Liu CX, Gong TT, Xu X, Ji C, Huang DH, Chang Q, Zhao YH. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. BMC Med. November 2018, s. 205. DOI10.1186/s12916-018-1193-5. PMID30415641.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
De Vries C, Gadzhanova S, Sykes MJ, Ward M, Roughead E. A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants. Drug Saf. March 2021, s. 291–312. ISSN0114-5916. DOI10.1007/s40264-020-01027-x. PMID33354752. S2CID229357583.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Sheehan DV, Kamijima K. An evidence-based review of the clinical use of sertraline in mood and anxiety disorders. Int Clin Psychopharmacol. March 2009, s. 43–60. DOI10.1097/yic.0b013e3282f4b616. PMID21456103.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Zuckerbrot RA, Cheung A, Jensen PS, Stein RE, Laraque D. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management. Pediatrics. March 2018. DOI10.1542/peds.2017-4081. PMID29483200. S2CID3591358.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Depression in children and young people: identifification and management: NICE Guideline. [s.l.]: National Institute for Health and Care Excellence (NICE), 25 June 2019. Dostupné online.Je zde použita šablona {{Cite book}} označená jako k „pouze dočasnému použití“.
Nemeroff CB. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J Psychiatr Res. 2007, s. 189–206. DOI10.1016/j.jpsychires.2006.05.008. PMID16870212.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
MacQueen G, Born L, Steiner M. The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders. CNS Drug Reviews. 2001, s. 1–24. DOI10.1111/j.1527-3458.2001.tb00188.x. PMID11420570.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN, Geddes J, Gilbody S, Haddad PM, Katona C, Lewis G, Malizia A, McAllister-Williams RH, Ramchandani P, Scott J, Taylor D, Uher R. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. May 2015, s. 459–525. Dostupné online. DOI10.1177/0269881115581093. PMID25969470. S2CID8142581.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, Faraone SV. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. The American Journal of Psychiatry. November 2003, s. 1919–28. Dostupné online. DOI10.1176/appi.ajp.160.11.1919. PMID14594734. S2CID8711232.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Flament MF, Bisserbe JC. Pharmacologic treatment of obsessive-compulsive disorder: comparative studies. The Journal of Clinical Psychiatry. 1997, s. 18–22. PMID9393392.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Blier P, Habib R, Flament MF. Pharmacotherapies in the management of obsessive-compulsive disorder. Canadian Journal of Psychiatry. June 2006, s. 417–30. DOI10.1177/070674370605100703. PMID16838823. S2CID17133521.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. October 2004, s. 1969–76. DOI10.1001/jama.292.16.1969. PMID15507582.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Sousa MB, Isolan LR, Oliveira RR, Manfro GG, Cordioli AV. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder. The Journal of Clinical Psychiatry. July 2006, s. 1133–9. Dostupné v archivu pořízeném z originálu dne 12 February 2020. DOI10.4088/JCP.v67n0717. PMID16889458. S2CID25130472.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Clayton AH, Stewart RS, Fayyad R, Clary CM. Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies. Archives of Women's Mental Health. May 2006, s. 151–7. DOI10.1007/s00737-005-0111-y. PMID16292466. S2CID20606054.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R. Sertraline treatment of panic disorder: response in patients at risk for poor outcome. J Clin Psychiatry. December 2000, s. 922–7. DOI10.4088/JCP.v61n1206. PMID11206597.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Sanchez C, Reines EH, Montgomery SA. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?. International Clinical Psychopharmacology. July 2014, s. 185–96. DOI10.1097/YIC.0000000000000023. PMID24424469.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
dailymed.nlm.nih.gov
DailyMed - ZOLOFT- sertraline hydrochloride tablet, film coated ZOLOFT- sertraline hydrochloride solution, concentrate [online]. Dostupné online.Je zde použita šablona {{Cite web}} označená jako k „pouze dočasnému použití“.
semanticscholar.org
api.semanticscholar.org
Lee DJ, Schnitzlein CW, Wolf JP, Vythilingam M, Rasmusson AM, Hoge CW. Psychotherapy Versus Pharmacotherapy for Posttraumatic Stress Disorder: Systemic Review and Meta-Analyses to Determine First-Line Treatments. Depression and Anxiety. September 2016, s. 792–806. Dostupné online. DOI10.1002/da.22511. PMID27126398. S2CID20190202.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
De Vries C, Gadzhanova S, Sykes MJ, Ward M, Roughead E. A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants. Drug Saf. March 2021, s. 291–312. ISSN0114-5916. DOI10.1007/s40264-020-01027-x. PMID33354752. S2CID229357583.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Zuckerbrot RA, Cheung A, Jensen PS, Stein RE, Laraque D. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management. Pediatrics. March 2018. DOI10.1542/peds.2017-4081. PMID29483200. S2CID3591358.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, Dickens C, Ferrier IN, Geddes J, Gilbody S, Haddad PM, Katona C, Lewis G, Malizia A, McAllister-Williams RH, Ramchandani P, Scott J, Taylor D, Uher R. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. May 2015, s. 459–525. Dostupné online. DOI10.1177/0269881115581093. PMID25969470. S2CID8142581.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, Faraone SV. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. The American Journal of Psychiatry. November 2003, s. 1919–28. Dostupné online. DOI10.1176/appi.ajp.160.11.1919. PMID14594734. S2CID8711232.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Blier P, Habib R, Flament MF. Pharmacotherapies in the management of obsessive-compulsive disorder. Canadian Journal of Psychiatry. June 2006, s. 417–30. DOI10.1177/070674370605100703. PMID16838823. S2CID17133521.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Sousa MB, Isolan LR, Oliveira RR, Manfro GG, Cordioli AV. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder. The Journal of Clinical Psychiatry. July 2006, s. 1133–9. Dostupné v archivu pořízeném z originálu dne 12 February 2020. DOI10.4088/JCP.v67n0717. PMID16889458. S2CID25130472.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Clayton AH, Stewart RS, Fayyad R, Clary CM. Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies. Archives of Women's Mental Health. May 2006, s. 151–7. DOI10.1007/s00737-005-0111-y. PMID16292466. S2CID20606054.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
pdfs.semanticscholar.org
Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, Faraone SV. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. The American Journal of Psychiatry. November 2003, s. 1919–28. Dostupné online. DOI10.1176/appi.ajp.160.11.1919. PMID14594734. S2CID8711232.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
Sousa MB, Isolan LR, Oliveira RR, Manfro GG, Cordioli AV. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder. The Journal of Clinical Psychiatry. July 2006, s. 1133–9. Dostupné v archivu pořízeném z originálu dne 12 February 2020. DOI10.4088/JCP.v67n0717. PMID16889458. S2CID25130472.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
unl.edu
digitalcommons.unl.edu
Lee DJ, Schnitzlein CW, Wolf JP, Vythilingam M, Rasmusson AM, Hoge CW. Psychotherapy Versus Pharmacotherapy for Posttraumatic Stress Disorder: Systemic Review and Meta-Analyses to Determine First-Line Treatments. Depression and Anxiety. September 2016, s. 792–806. Dostupné online. DOI10.1002/da.22511. PMID27126398. S2CID20190202.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
web.archive.org
Sousa MB, Isolan LR, Oliveira RR, Manfro GG, Cordioli AV. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder. The Journal of Clinical Psychiatry. July 2006, s. 1133–9. Dostupné v archivu pořízeném z originálu dne 12 February 2020. DOI10.4088/JCP.v67n0717. PMID16889458. S2CID25130472.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
worldcat.org
De Vries C, Gadzhanova S, Sykes MJ, Ward M, Roughead E. A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants. Drug Saf. March 2021, s. 291–312. ISSN0114-5916. DOI10.1007/s40264-020-01027-x. PMID33354752. S2CID229357583.Je zde použita šablona {{Cite journal}} označená jako k „pouze dočasnému použití“.
